CLIC1 antibody conjugated nanoscale contrast agent as a sensitive and targeted molecular imaging probe for gallbladder cancer diagnosis
- 26 February 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (29) , 24104-24110
Abstract
CLIC1 antibody-conjugated nano-scale contrast agents exhibit a fast and sensitive detection of gallbladder tumors and may be used in the future as powerful targeted molecular imaging probes for gallbladder cancer diagnosis.Keywords
This publication has 38 references indexed in Scilit:
- Aqueous synthesis of PEGylated copper sulfide nanoparticles for photoacoustic imaging of tumorsNanoscale, 2015
- The surgical management of gallbladder cancerExpert Review of Gastroenterology & Hepatology, 2014
- Aspects on gallbladder cancer in 2014Current Opinion in Gastroenterology, 2014
- Gallbladder CancerSurgical Clinics of North America, 2014
- Synthesis of PEGylated low generation dendrimer-entrapped gold nanoparticles for CT imaging applicationsNanoscale, 2014
- Near-infrared fluorescent ribonuclease-A-encapsulated gold nanoclusters: preparation, characterization, cancer targeting and imagingNanoscale, 2012
- Inorganic nanoparticle-based contrast agents for molecular imagingTrends in Molecular Medicine, 2010
- Differential Diagnostic and Staging Accuracies of High Resolution Ultrasonography, Endoscopic Ultrasonography, and Multidetector Computed Tomography for Gallbladder Polypoid Lesions and Gallbladder CancerAnnals of Surgery, 2009
- Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor TargetingSmall, 2009
- Size and Surface Effects on the MRI Relaxivity of Manganese Ferrite Nanoparticle Contrast AgentsNano Letters, 2007